Insufficient intrinsic factor production, common in older adults due to age-related absorption decline, can also lead to deficiency
In D-galactose-induced aging mice, oral administration of the product significantly increased NAD+ levels in liver and adipose tissue, activated mitochondrial energy metabolism pathways, improved insulin sensitivity, lowered blood glucose and lipid levels, reduced visceral fat accumulation, and increased energy expenditure, alleviating fatigue and abnormal body weight associated with aging
However, it may not be suitable for larger volume injections
Regulatory Note on Injectable GHK-Cu It is important to note that the FDA added injectable GHK-Cu to a high-risk compounded substance list in September 2023
Larazotide is a peptide designed to tighten these loose junctions and help close the gaps in the gut lining